YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 21443688)

Published in Cancer Sci on May 09, 2011

Authors

Shu Tian1, Haitian Quan, Chengying Xie, Haiyi Guo, Fangfang Lü, Yongping Xu, Jin Li, Liguang Lou

Author Affiliations

1: Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Associated clinical trials:

Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma (Spark-AL003) | NCT03709953

Articles citing this

Clinical advances in the development of novel VEGFR2 inhibitors. Ann Transl Med (2014) 1.24

Apatinib for molecular targeted therapy in tumor. Drug Des Devel Ther (2015) 0.98

Novel targeted agents for gastric cancer. J Hematol Oncol (2012) 0.96

Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report. Onco Targets Ther (2016) 0.93

Clinical management of advanced gastric cancer: the role of new molecular drugs. World J Gastroenterol (2014) 0.92

Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer. Onco Targets Ther (2015) 0.89

The progress of targeted therapy in advanced gastric cancer. Biomark Res (2013) 0.89

The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature. Medicine (Baltimore) (2016) 0.87

Molecular targeted agents for gastric cancer: a step forward towards personalized therapy. Cancers (Basel) (2013) 0.87

Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World J Gastroenterol (2015) 0.87

A Case Report of Gastrointestinal Hemorrhage and Perforation During Apatinib Treatment of Gastric Cancer. Medicine (Baltimore) (2015) 0.85

Molecular targeted therapy for advanced gastric cancer. Korean J Intern Med (2013) 0.84

Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma. Oncotarget (2016) 0.82

Successful treatment of angiosarcoma of the scalp with apatinib: a case report. Onco Targets Ther (2016) 0.81

DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo. Acta Pharmacol Sin (2016) 0.80

Metastatic gastric cancer treatment: Second line and beyond. World J Gastroenterol (2016) 0.79

Significant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib: A case report. Medicine (Baltimore) (2016) 0.79

The changing landscape of clinical trial and approval processes in China. Nat Rev Clin Oncol (2017) 0.78

Gastric Cancer: New Drugs - New Strategies. Gastrointest Tumors (2015) 0.78

Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage. Int J Nanomedicine (2016) 0.77

Angiogenesis inhibitors in gastric and gastroesophageal junction cancer. Gastric Cancer (2015) 0.76

Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer. Oncotarget (2017) 0.76

DKK4 enhances resistance to chemotherapeutics 5-Fu and YN968D1 in colorectal cancer cells. Oncol Lett (2016) 0.75

Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects. Int J Nanomedicine (2017) 0.75

Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer. Oncotarget (2017) 0.75

Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review. Oncotarget (2017) 0.75

Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma. Oncotarget (2017) 0.75

Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China. Oncotarget (2017) 0.75

The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer. Best Pract Res Clin Endocrinol Metab (2017) 0.75

Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report. Onco Targets Ther (2017) 0.75

High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progression. Cancer Sci (2017) 0.75

Articles by these authors

Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology (2015) 2.81

The long rather than the short allele of 5-HTTLPR predisposes Han Chinese to anxiety and reduced connectivity between prefrontal cortex and amygdala. Neurosci Bull (2013) 2.78

KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell (2012) 2.55

Complicated acute type B dissection: is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv (2008) 2.47

Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell (2010) 2.46

KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies. Lung Cancer (2009) 2.27

COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations. Clin Chem (2009) 2.17

Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid X receptor. Gastroenterology (2012) 2.05

Molecular characterization of meiotic recombination across the 140-kb multigenic a1-sh2 interval of maize. Proc Natl Acad Sci U S A (2002) 1.98

On evaluating molecular-docking methods for pose prediction and enrichment factors. J Chem Inf Model (2006) 1.90

Impact of duty hours restrictions on quality of care and clinical outcomes. Am J Med (2007) 1.81

Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II). J Clin Oncol (2012) 1.73

PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib. BMC Cancer (2011) 1.73

A biosecure composting system for disposal of cattle carcasses and manure following infectious disease outbreak. J Environ Qual (2009) 1.72

PCR-based methods for the enrichment of minority alleles and mutations. Clin Chem (2009) 1.65

Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet (2012) 1.64

Deer antler base as a traditional Chinese medicine: a review of its traditional uses, chemistry and pharmacology. J Ethnopharmacol (2012) 1.63

Cyclic AMP inhibition of proliferation of hepatocellular carcinoma cells is mediated by Akt. Cancer Biol Ther (2005) 1.46

Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol (2004) 1.45

Maize Mu transposons are targeted to the 5' untranslated region of the gl8 gene and sequences flanking Mu target-site duplications exhibit nonrandom nucleotide composition throughout the genome. Genetics (2002) 1.44

Observation of microsphere movement driven by optical pulse. Opt Lett (2011) 1.42

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study). Gastric Cancer (2014) 1.41

Role of age in acute type A aortic dissection outcome: report from the International Registry of Acute Aortic Dissection (IRAD). J Thorac Cardiovasc Surg (2010) 1.41

Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations. Nucleic Acids Res (2010) 1.38

Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int J Pharm (2006) 1.37

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies. BMC Cancer (2010) 1.35

Do we really need closed-suction drainage in total hip arthroplasty? A meta-analysis. Int Orthop (2013) 1.35

Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis (2006) 1.32

Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population. Mol Carcinog (2013) 1.32

Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. Am J Hum Genet (2013) 1.31

First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm Bowel Dis (2013) 1.25

Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J Neurosci (2002) 1.24

Simultaneously typing nine serotypes of enteroviruses associated with hand, foot, and mouth disease by a GeXP analyzer-based multiplex reverse transcription-PCR assay. J Clin Microbiol (2011) 1.23

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer. Int J Cancer (2014) 1.22

Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci (2013) 1.22

Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg (2013) 1.20

Oxidative lipidomics of hyperoxic acute lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation. Am J Physiol Lung Cell Mol Physiol (2010) 1.19

YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice. Addict Biol (2011) 1.16

Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: a meta-analysis of 22 studies. Eur J Cancer (2010) 1.16

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Control Release (2010) 1.15

Depression and associated factors in internal migrant workers in China. J Affect Disord (2011) 1.13

The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J Virol (2003) 1.13

Computer-assisted orbital volume measurement in the surgical correction of late enophthalmos caused by blowout fractures. Ophthal Plast Reconstr Surg (2003) 1.13

Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. PLoS One (2012) 1.12

Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am J Pathol (2004) 1.12

Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors. PLoS One (2013) 1.11

MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region. Biochem Biophys Res Commun (2010) 1.10

Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol (2013) 1.09

BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer. Mol Cancer (2010) 1.08

Multiple aneurysms of distal anterior cerebral artery associated with a cerebral arteriovenous malformation. Neurol India (2010) 1.08

Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis. Cancer Res (2006) 1.08

Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol (2012) 1.08

Thermal stability and inactivation of hepatitis C virus grown in cell culture. Virol J (2010) 1.07

Hydroxyapatite nucleation and growth mechanism on electrospun fibers functionalized with different chemical groups and their combinations. Biomaterials (2010) 1.06

Compact designer TALENs for efficient genome engineering. Nat Commun (2013) 1.06

DNA degradation test predicts success in whole-genome amplification from diverse clinical samples. J Mol Diagn (2007) 1.05

Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery. Appl Environ Microbiol (2008) 1.05

Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res (2007) 1.05

Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population. PLoS One (2012) 1.05

Late reconstruction of the complex orbital fractures with computer-aided design and computer-aided manufacturing technique. J Craniofac Surg (2007) 1.05

An update on chemotherapy of colorectal liver metastases. World J Gastroenterol (2012) 1.05

Primary treatment of acute dacryocystitis by endoscopic dacryocystorhinostomy with silicone intubation guided by a soft probe. Ophthalmology (2009) 1.05

Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation (2008) 1.05

Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol (2010) 1.04

Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease. Medicine (Baltimore) (2014) 1.03

A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery. Biomaterials (2013) 1.03

TNF gene polymorphisms and Helicobacter Pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol (2005) 1.03

Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference. Jpn J Clin Oncol (2010) 1.03

Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomib. Drug Metab Dispos (2012) 1.02

On the mitogenic properties of Rap1b: cAMP-induced G(1)/S entry requires activated and phosphorylated Rap1b. Proc Natl Acad Sci U S A (2002) 1.01

Serotonin transporter gene-linked polymorphic region (5-HTTLPR) influences decision making under ambiguity and risk in a large Chinese sample. Neuropharmacology (2010) 1.01

Selective hydrogenation by Pd nanoparticles embedded in polyelectrolyte multilayers. J Am Chem Soc (2004) 1.00

Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer. BMC Cancer (2014) 0.99

Unequal sister chromatid and homolog recombination at a tandem duplication of the A1 locus in maize. Genetics (2006) 0.99

Oncogenic role of the chromobox protein CBX7 in gastric cancer. J Exp Clin Cancer Res (2010) 0.99

Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer. J Int Med Res (2013) 0.99

Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores. PLoS One (2009) 0.99

Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings. PLoS One (2011) 0.98

Gastric carcinoma in China: Current status and future perspectives (Review). Oncol Lett (2010) 0.98

Simultaneous determination of stilbenes, phenolic acids, flavonoids and anthraquinones in Radix polygoni multiflori by LC-MS/MS. J Pharm Biomed Anal (2011) 0.98

Surgical treatment for patients with Krukenberg tumor of stomach origin: clinical outcome and prognostic factors analysis. PLoS One (2013) 0.98

A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers. Cancer Biol Ther (2009) 0.97

Influence of extracellular polymeric substances on Pseudomonas aeruginosa transport and deposition profiles in porous media. Environ Sci Technol (2007) 0.97

COLD-PCR: improving the sensitivity of molecular diagnostics assays. Expert Rev Mol Diagn (2011) 0.97

MicroRNA expression profiling in diabetic GK rat model. Acta Biochim Biophys Sin (Shanghai) (2009) 0.97

Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity. Leuk Lymphoma (2007) 0.97

Apatinib for the treatment of gastric cancer. Expert Opin Pharmacother (2014) 0.97

Genome-wide association analysis of red blood cell traits in African Americans: the COGENT Network. Hum Mol Genet (2013) 0.97

Agmatine: clinical applications after 100 years in translation. Drug Discov Today (2013) 0.96

Biological role of surface Toxoplasma gondii antigen in development of vaccine. World J Gastroenterol (2006) 0.96

Novel targeted agents for gastric cancer. J Hematol Oncol (2012) 0.96

Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer's disease rat model. Neurosci Lett (2007) 0.96

Visual detection of high-risk human papillomavirus genotypes 16, 18, 45, 52, and 58 by loop-mediated isothermal amplification with hydroxynaphthol blue dye. J Clin Microbiol (2011) 0.96

Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study. J Clin Gastroenterol (2007) 0.95

Utility of in vitro interferon-γ release assay in differential diagnosis between intestinal tuberculosis and Crohn's disease. J Dig Dis (2013) 0.95

A sub-pathway-based approach for identifying drug response principal network. Bioinformatics (2010) 0.95

Evidence of human papilloma virus infection and its epidemiology in esophageal squamous cell carcinoma. World J Gastroenterol (2006) 0.95

Genotyping of 11 human papillomaviruses by multiplex PCR with a GeXP analyzer. J Med Virol (2012) 0.95

CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population. Mol Biol Rep (2012) 0.94